Search hospitals > Illinois > Danville
Carle at The Riverfront
Claim this profileDanville, Illinois 61832
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Tumors
Conducts research for Recurrence
Conducts research for Adenocarcinoma
194 reported clinical trials
12 medical researchers
Summary
Carle at The Riverfront is a medical facility located in Danville, Illinois. This center is recognized for care of Cancer, Breast Cancer, Tumors, Recurrence, Adenocarcinoma and other specialties. Carle at The Riverfront is involved with conducting 194 clinical trials across 375 conditions. There are 12 research doctors associated with this hospital, such as Vamsi K. Vasireddy, Maria T. Grosse-Perdekamp, Suparna Mantha, and Kendrith Rowland, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Vamsi K. VasireddyCarle Cancer Center2 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
30 reported clinical trials
55 drugs studied
Maria T. Grosse-PerdekampCarle Cancer Center2 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
29 reported clinical trials
60 drugs studied
Suparna ManthaCarle Cancer Center4 years of reported clinical research
Studies Cancer
Studies Adenocarcinoma
29 reported clinical trials
64 drugs studied
Kendrith Rowland, MDCarle Cancer Center1 year of reported clinical research
Expert in Cancer
Studies Breast Cancer
29 reported clinical trials
59 drugs studied
Clinical Trials running at Carle at The Riverfront
Breast Cancer
Lung Cancer
Cancer
Prostate Cancer
Pancreatic Cancer
Tumors
Renal Cell Carcinoma
Non-Small Cell Lung Cancer
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Carle at The Riverfront?
Carle at The Riverfront is a medical facility located in Danville, Illinois. This center is recognized for care of Cancer, Breast Cancer, Tumors, Recurrence, Adenocarcinoma and other specialties. Carle at The Riverfront is involved with conducting 194 clinical trials across 375 conditions. There are 12 research doctors associated with this hospital, such as Vamsi K. Vasireddy, Maria T. Grosse-Perdekamp, Suparna Mantha, and Kendrith Rowland, MD.